Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Cloud and AI demand still looks increasingly strong

NEXTDC
3:27pm
May 5, 2025
Roughly three months ago Data Centre stocks globally started de-rating following weaker than anticipated quarterly results from Cloud Service Providers (CSP). The CSPs in aggregate missed consensus expectations for Cloud revenue growth, mostly due to lack of supply. Investors were nervous AI demand was weakening. The April 2025 CSP quarterly results were generally better than feared. MSFT’s Cloud revenue was a beat, Google’s was in line and AWS was slightly weaker. Commentary was incrementally more bullish for AI and Data Centre demand. Capex forecasts for MSFT, Alphabet, Amazon and Meta lifted an average of ~2% pa. Capex is forecast to be US$309bn in CY25, + 46% YoY. Quarterly data points remain supportive for Data Centres including NXT.

Tariff uncertainty impacts US demand

Reliance Worldwide
3:27pm
May 5, 2025
RWC’s trading update was softer than expected with FY25 guidance for sales and earnings decreased due mainly to a deterioration in the US market over the past few months. Management also provided an estimate on the impact of US tariffs on earnings. While the expected impact in FY26 is greater than our base case assumption, the key positive is that full mitigation is expected by FY27. We adjust FY25/26/27F EBITDA by -4%/-7%/+3%. Our target price falls to $4.00 (from $4.15 previously) and we maintain our Hold rating. While we remain positive on RWC over the long-term with cost-out and restructuring activities to drive operating leverage when economic conditions improve, the timing of a recovery remains uncertain and could potentially be pushed out as consumers become more cautious due to the introduction of tariffs.

Very Big, Very Good.

Turaco Gold
3:27pm
May 5, 2025
TCG has released an updated Mineral Resource Estimate (MRE), reporting a material increase of over 40% in contained ounces. Afema now stands at 90.8Mt @ 1.2g/t Au for 3.55Moz. All deposits remain open, and resource growth is expected to continue, supported by three rigs currently active on site. Notably, recent high-grade results from Begnopan (e.g. 34m @ 3.44g/t Au) are not yet included in the current MRE. Improved resource conversion (+17% Indicated), favourable metallurgy, and imminent resource growth support confidence in our production scenario and provide a clear line of sight to a 180–200kozpa operation. We reiterate our SPECULATIVE BUY rating, with TCG remaining our preferred small/mid cap gold stock for 2025. Our PT increases to A$1.29 (previously A$1.10).

US installed base growth slower than expected

ImpediMed
3:27pm
May 5, 2025
IPD reported its 3Q25 cashflow report where most metrics are heading in the right direction. However, we were disappointed with the growth in the US installed base. To address this issue additional experience sales staff have been employed and management speaks to an increase in the installed base in subsequent quarters. Debt funding has been arranged and provides a runway to achieve sales growth in the US. We have revised down our forecasts to reflect the lower installed base growth, which sees our DCF based valuation fall to A$0.15 (from A$0.16). Our Speculative Buy recommendation has been maintained.

Early days in strategic realignment

Micro-X
3:27pm
May 5, 2025
MX1 has recently raised capital, added a strategic investor and realigned its business to focus on medical imaging, deprioritising security and defence. The realignment makes sense and the business is funded to execute on the strategy. It’s early days in the realignment and customer receipts from imaging are still modest, although a major US hospital is evaluating the Rover+ mobile x-ray unit which could result in material sales over time. We have made no changes to forecasts or our target price (A$0.17). We maintain our Speculative Buy recommendation.

Pending promises

Mach7 Technologies
3:27pm
May 5, 2025
M7T produced a mixed quarterly report with no new material contract wins and a small contraction of subscription value, however the existing customer base continues to grow nicely, advancing the operating cashflow further into the black. Overdue a new contract or two, we look to 4Q in anticipation of movement on this front with several said to be in final stages. Looking forward, a change in leadership with ex-Volpara CEO Teri Thomas taking the reins in July may warrant a shift in strategy but we view the underlying business as healthy albeit slow on the new contract front. We continue to see material value here, particularly at these levels.

Building the base

Aroa Biosurgery
3:27pm
May 5, 2025
ARX posted its 4Q25 cashflow report which delivered results largely in line with expectations. Importantly, FY25 guidance has been reconfirmed. Myriad™ sales growth of 32% over the year was the highlight and it remains a key growth driver moving forward. We have made no changes to forecasts and our target price remains unchanged at A$0.93. We have moved our recommendation to Speculative Buy (from Add) with over 100% upside to the target price.

International Spotlight

Hermes
3:27pm
May 5, 2025
Hermès International, a French high-fashion luxury goods manufacturer, was founded in 1837 by Thierry Hermès. Hermès is known for its high-end craftsmanship. It specialises in leather goods, lifestyle accessories, home furnishings, fragrances, jewellery, watches, and ready-to-wear apparel. Many of its products have an equestrian theme, reflecting Hermès’ heritage in saddle making. Some of Hermès products, notably the Birkin and Kelly handbags, as well as its silk scarves, have attained iconic status in consumer culture.

A$30m hit from tariffs

Corporate Travel Management
3:27pm
May 4, 2025
Given recent downgrades from other travel/airline industry peers due to political and macro-economic uncertainty, CTD’s downgrade wasn’t a surprise. However, the quantum was greater than expected and highlights the company’s material operating deleverage to unforeseen lower client activity. New guidance now implies that 2H25 will be weaker than the 2H24. Importantly, FY25 new client wins of A$1.6bn have materially beaten guidance of A$1bn and will underpin strong growth into FY26/27. Due to all the uncertainty, the question is whether operating conditions will get worse before they get better. However, what we do know from past economic and geopolitical events, is that after a downturn, travel demand rebounds. We are buyers of CTD during this period of short term uncertainty and share price weakness because when operating conditions ultimately improve, both its earnings and share price leverage to the upside will be material.

A new chapter begins

Amcor
3:27pm
May 2, 2025
AMC’s 3Q25 result overall was slightly softer than expected with management lowering the top-end of FY25 underlying EPS guidance. Volumes were higher across all regions excluding North America where consumer demand was generally weaker. We adjust our earnings forecasts following the update to FY25 earnings guidance and now include Berry Global earnings following the closure of the deal. While the global macroeconomic outlook is becoming more uncertain and the integration of Berry Global does not come without risks, longer term the combination is expected to give AMC access to higher growth and higher margin segments as well as a broader product portfolio that will allow the company to better service customers in more regions. Trading on 10.8x FY26F PE and 6.4% yield, we think the valuation is attractive and move to an Add rating (from Hold). Our target price decreases slightly to $16.00 (from $16.45 previously).

News & Insights

Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more
Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more